Special report: vaccines for the treatment of prostate cancer.
D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000037:antagonists & inhibitors / Q000276:immunology*; D011471:Prostatic Neoplasms / Q000276:immunology* / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D013534:Survival; D016896:Treatment Outcome; D014481:United States
D019496:Cancer Vaccines; D017430:Prostate-Specific Antigen